BIOGEN INC (IDP.DE) Forecast, Price Target & Analyst Ratings

FRA:IDPUS09062X1037

Current stock price

148.86 EUR
-5.69 (-3.68%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOGEN INC (IDP.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€177.03
+ 18.92% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$3.11
Revenue Estimate
2.293B

ChartMill Buy Consensus

Rating
73.02%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€177.03
Upside
+ 18.92%
From current price of €148.86 to mean target of €177.03, Based on 43 analyst forecasts
Low
€121.52
Median
€176.79
High
€229.70

Price Target Revisions

1 Month
0.00%
3 Months
13.90%

Price Target Summary

43 Wall Street analysts provided a forecast for the next 12 months for IDP.DE. The average price target is 177.03 EUR. This implies a price increase of 18.92% is expected in the next year compared to the current price of 148.86.
The average price target has been revised upward by 13.9% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

IDP Current Analyst RatingIDP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15 20

Analyst Ratings History

IDP Historical Analyst RatingsIDP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30 40

Analyst Ratings Consensus

ChartMill Buy Consensus
73.02%
IDP.DE was analyzed by 43 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about IDP.DE.
In the previous month the buy percentage consensus was at a similar level.
IDP.DE was analyzed by 43 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-08-02MizuhoMaintains Neutral
2021-07-27Canaccord GenuityMaintains Buy
2021-07-23RBC CapitalMaintains Sector Perform
2021-07-23Morgan StanleyMaintains Overweight
2021-07-16Morgan StanleyMaintains Overweight
2021-06-28RBC CapitalMaintains Sector Perform
2021-06-18Piper SandlerUpgrade Neutral -> Overweight
2021-06-14Truist SecuritiesMaintains Buy
2021-06-14Goldman SachsMaintains Neutral
2021-06-11BernsteinUpgrade Market Perform -> Outperform
2021-06-10UBSUpgrade Neutral -> Buy
2021-06-10SVB LeerinkMaintains Outperform
2021-06-08William BlairUpgrade Market Perform -> Outperform
2021-06-08RBC CapitalMaintains Sector Perform
2021-06-08BarclaysMaintains Equal-Weight
2021-06-08BairdUpgrade Underperform -> Neutral
2021-06-08Morgan StanleyMaintains Overweight
2021-06-08CitigroupUpgrade Sell -> Neutral
2021-06-08JefferiesMaintains Buy
2021-06-08HC Wainwright & Co.Maintains Buy
2021-05-18OppenheimerMaintains Outperform
2021-04-19Morgan StanleyMaintains Overweight
2021-04-12WedbushMaintains Neutral
2021-02-17Cantor FitzgeraldMaintains Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$3.11
Revenue Estimate
2.293B
Revenue Q2Q
-5.68%
EPS Q2Q
3.05%
Number of Analysts
28

Next Earnings Revisions

Revenue (1 Month)
0.35%
Revenue (3 Months)
-0.48%
EPS (1 Month)
-0.55%
EPS (3 Months)
-13.69%

Next Earnings Summary

IDP.DE is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 3.11 EUR and the consensus revenue estimate is 2.29B EUR.
The next earnings revenue estimate has been revised downward by 0.48% in the past 3 months.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IDP.DE revenue by date.IDP.DE revenue by date.
9.836B
-3.32%
9.676B
-1.62%
9.891B
2.22%
9.733B
-1.59%
9.7B
-0.34%
9.771B
0.73%
9.724B
-0.48%
9.783B
0.61%
9.545B
-2.43%
9.559B
0.15%
9.338B
-2.31%
EBITDA
YoY % growth
IDP.DE ebitda by date.IDP.DE ebitda by date.
2.669B
-28.68%
3.325B
24.56%
3.572B
7.45%
3.342B
-6.45%
3.231B
-3.32%
3.332B
3.13%
3.304B
-0.84%
3.052B
-7.63%
3.959B
29.72%
4.377B
10.56%
4.838B
10.53%
EBIT
YoY % growth
IDP.DE ebit by date.IDP.DE ebit by date.
2.174B
-32.56%
2.651B
21.94%
2.793B
5.32%
2.938B
5.21%
2.969B
1.06%
3.083B
3.84%
3.083B3.051B
-1.04%
3.212B
5.28%
3.33B
3.67%
3.139B
-5.74%
Operating Margin
IDP.DE operating margin by date.IDP.DE operating margin by date.
22.11%27.40%28.23%30.19%30.61%31.55%31.71%31.19%33.65%34.84%33.62%
EPS
YoY % growth
IDP.DE eps by date.IDP.DE eps by date.
15.08
-18.27%
16.47
9.22%
15.29
-7.16%
16.08
5.16%
16.63
3.45%
17.64
6.02%
18.09
2.60%
18.19
0.51%
18.47
1.53%
19.17
3.84%
18.53
-3.39%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
3.11
3.05%
4.33
-20.76%
4.30
-10.51%
4.02
101.80%
3.69
18.71%
4.55
5.00%
4.36
1.28%
4.58
14.15%
Revenue
Q2Q % growth
2.293B
-5.68%
2.46B
-7.01%
2.514B
-0.82%
2.499B
9.63%
2.263B
-1.31%
2.442B
-0.73%
2.446B
-2.70%
2.426B
-2.92%
EBITDA
Q2Q % growth
630.9M
-26.83%
821.41M
-36.93%
837.7M
-34.25%
777.6M
-37.54%
N/AN/AN/AN/A
EBIT
Q2Q % growth
549.8M
-19.03%
794.42M
-14.11%
801.11M
15.37%
724.62M
55.83%
553.44M
0.66%
727.03M
-8.48%
709.14M
-11.48%
696.4M
-3.89%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IDP.DE Yearly Revenue VS EstimatesIDP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
IDP.DE Yearly EPS VS EstimatesIDP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.87%
EPS Next 5 Year
3.53%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-0.84%
Revenue Next 5 Year
-0.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
5.17%
EBIT Next 5 Year
1.28%

BIOGEN INC / IDP.DE Forecast FAQ

What is the average price target for BIOGEN INC (IDP.DE) stock?

43 analysts have analysed IDP.DE and the average price target is 177.03 EUR. This implies a price increase of 18.92% is expected in the next year compared to the current price of 148.86.

What is the next earnings date for IDP stock?

BIOGEN INC (IDP.DE) will report earnings on 2026-04-29.

What are the consensus estimates for BIOGEN INC (IDP.DE) next earnings?

The consensus EPS estimate for the next earnings of BIOGEN INC (IDP.DE) is 3.11 EUR and the consensus revenue estimate is 2.29B EUR.

What is the expected long term growth rate for BIOGEN INC (IDP.DE)?

The expected long term growth rate for BIOGEN INC (IDP.DE) is -0.84%.